Smart science to improve lives™
0 View basket
banner representing sustainability for the earth and vaccines

Formulate the future: Securing sustainable supply of critical ingredients for vaccines

We envision a future where everyone gets the vaccines they need. This reality relies on maintaining vaccine access and continuing to innovate in this realm. The responsibility is on us all to not only select sustainable ingredients, but to secure supply chains and sources that will not deplete in the future.

Future-ready vaccines start with sustainable supply 

Tomorrow’s vaccines depend on resilient, scalable supply chains that support both global health and the natural world. Building that future means choosing critical ingredients that deliver performance without compromising biodiversity. 

Squalene is a proven ingredient in vaccine adjuvant systems used in seasonal and pandemic vaccines. Traditionally sourced from shark liver, it presents a clear biodiversity challenge and highlights the need for a more sustainable alternative.

That challenge sits within a wider global agenda. IPBES (Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services), the leading global platform on biodiversity, translates science into action and helps policymakers and organisations understand why nature matters - and what to do to protect it. It works alongside the IPCC (Intergovernmental Panel on Climate Change) to show that climate change and nature loss are deeply connected - and that effective solutions must address both together. 

Partnering for Sustainably Sourced Squalene 

The strategic partnership with Amyris Inc., a leader in synthetic biology, helped accelerating the commercial availability of Sustainably Sourced Squalene that fulfils the stringent requirements from vaccine manufacturers while supporting supply security and reducing pressure on marine biodiversity. 

It is not only an example of how Croda implements our Commitment, to be Climate, Land, People, and Nature Positive by 2030. It further demonstrates how innovation, better data and collaboration can contribute to nature-positive transformation in line with IPBES’ advice. 

Contact us to continue your sustainable journey today!

The fusion of Amyris’s pioneering fermentation technology and Croda’s expertise in pharmaceutical-grade purification delivers a squalene solution that surpasses traditional standards for purity and stability. This unique synergy is fully aligned with Croda’s commitment to be the most sustainable supplier of innovative vaccine ingredients in a rapidly evolving global landscape.
Angela Kleiner

Angela Kleiner, Head of Insights & Innovation, Vaccine Adjuvants, Croda Pharma

Whitepaper: Vaccines for a more sustainable future

Cover of Vaccines for a more sustainable future whitepaper from Croda Pharma
692.3 KB
blue washed image of male at computer wearing hard hat

Exceptional standards in adjuvant manufacturing

Our aseptic process ensures we can deliver sterile aluminium according to GMP EudraLex Volume 4. We are one of the only companies worldwide to operate at such premium standards. Our Quality Management System is continually improved through established metrics.
Blue washed image of vaccine being injected into arm

A history of supporting vaccines

As a key player in adjuvant development since 1939, our adjuvants have consistently been featured in countless peer-reviewed papers. Our leading R&D capabilities demonstrate our determination to advance drug delivery systems and novel vaccine adjuvants to tackle even more pathogens.
Blue washed image of female in lab

Dedicated to your vaccine success

Developing and manufacturing vaccines is a costly challenge. Our team of experts are committed to helping you choose the right adjuvant for your needs. Save time and money by leveraging our decades worth of experience.
Please provide your first name
Please provide your last name
Please select your country
Email is not valid
We need your consent
Please complete the recaptcha and resubmit the form.

Supporting Literature

Enter your contact details to receive supporting materials.

Empowering the development of tomorrow's vaccines

Empowering the development of tomorrows vaccines brochure cover